Precipio, Inc. (PRPO)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$31.65
+3.09%
Mkt Cap $44.94M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | — | $7.97M | — | — | $0.33 | — | — | — |
| Q4 2025 Nov 14, 2025 | — | $6.16M | — | — | -$0.05 | — | — | — |
| Q3 2025 Aug 13, 2025 | — | $5.65M | — | — | $0.05 | — | — | — |
| Q2 2025 May 14, 2025 | — | $4.26M | — | — | -$0.59 | — | — | — |
| Q1 2025 Mar 27, 2025 | $8.01M | $5.45M | -31.98% | $0.74 | -$0.23 | -131.08% | — | — |
| Q4 2024 Nov 6, 2024 | $7.29M | $4.60M | -36.95% | $0.40 | -$0.42 | -205.00% | — | — |
| Q3 2024 Aug 13, 2024 | $4.33M | $4.44M | +2.59% | -$0.05 | -$0.83 | -1560.00% | — | — |
| Q2 2024 May 14, 2024 | $4.33M | $3.43M | -20.72% | -$0.93 | -$1.46 | -56.99% | — | — |
| Q1 2024 Mar 29, 2024 | $4.36M | $4.33M | -0.71% | -$0.93 | -$0.41 | +55.91% | — | — |
| Q4 2023 Nov 13, 2023 | $4.90M | $3.74M | -23.71% | -$1.21 | -$1.04 | +14.05% | — | — |
| Q3 2023 Aug 11, 2023 | $2.70M | $3.53M | +30.85% | -$0.10 | -$1.80 | -1700.00% | — | — |
| Q2 2023 May 12, 2023 | $760.00K | $2.82M | +270.66% | -$0.13 | -$2.60 | -1900.00% | — | — |
| Q1 2023 Mar 30, 2023 | $2.00M | $2.39M | +19.55% | $0.14 | -$2.00 | -1528.57% | — | — |
| Q4 2022 Nov 10, 2022 | $5.00M | $2.21M | -55.68% | -$0.80 | -$2.80 | -250.00% | — | — |
| Q3 2022 Aug 11, 2022 | $2.36M | $2.36M | +0.00% | -$1.80 | -$1.80 | +0.00% | — | — |
| Q2 2022 May 11, 2022 | $4.81M | $2.45M | -49.08% | -$1.00 | -$4.00 | -300.00% | — | — |
| Q1 2022 Mar 30, 2022 | — | $2.44M | — | — | -$1.80 | — | — | — |
| Q4 2021 Nov 12, 2021 | — | $2.25M | — | — | -$1.60 | — | — | — |
| Q3 2021 Aug 12, 2021 | $2.34M | $2.34M | +0.00% | -$0.10 | -$2.80 | -2700.00% | — | — |
| Q2 2021 May 14, 2021 | $1.94M | $1.82M | -6.03% | -$0.10 | -$1.60 | -1500.00% | — | — |